SAN FRANCISCO and SUZHOU, China, May 31, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major...
from PR Newswire: https://ift.tt/3uAf0a5
No comments:
Post a Comment